Metabolic research

Retatrutide and 5-Amino-1MQ studies examine incretin-receptor pharmacology and enzyme targets in nicotinamide and adipocyte metabolism.

Retatrutide and Tirzepatide have published human-interventional studies, while 5-Amino-1MQ has adipocyte and mouse research. Retatrutide, Tirzepatide, and 5-Amino-1MQ therefore span human-interventional and preclinical evidence. Studies for those molecules identify model, endpoint, timepoint, evidence tier, and primary source on every published evidence profile.

Sources: Coskun et al., Cell Metabolism 2022 · Jastreboff et al., NEJM 2023 · Jastreboff et al., NEJM 2022 · Neelakantan et al., Biochemical Pharmacology 2018